ReviewCanadian journal of gastroenterology = Journal canadien de gastroenterologie2011
Endoscopic treatment of obesity.
Review in Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05420506 (Treatment of Obesity Without Surgical Intervention by Reversible Reduction of the Small Intestinal Absorption Area), which is not on this map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Treatment of Obesity Without Surgical Intervention by Reversible Reduction of the Small Intestinal Absorption Area
Who cites it
12 citing papers in PubMed, 35 citations in OpenAlex.
- A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels.Obesity surgery · 2013Trial
- Effects of Intraparietal Gastric Botulinum Toxin-A Injection on Weight Loss: A Retrospective Study of 500 Patients.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025Article
- Intra-gastric balloons - The past, present and future.Annals of medicine and surgery (2012) · 2021Review
- Gastric Botulinum Toxin-A Application for Weight Loss Therapy.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021Article
- Efficacy and Safety of Intragastric Balloon Placements in 1600 Case, an Experience from the Middle East.Obesity surgery · 2019Article
- Various Intragastric Balloons Under Clinical Investigation.Clinical endoscopy · 2018Article
- Trends in BMI, Glycemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL).Obesity surgery · 2018Article
- ASMBS pediatric metabolic and bariatric surgery guidelines, 2018.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2018Review
- The Role of Endoscopic Intra-Gastric Botulinum Toxin-A for Obesity Treatment.Obesity surgery · 2017Review
- Impact of obesity treatment on gastroesophageal reflux disease.World journal of gastroenterology · 2016Review
- Role of endoscopy in the bariatric surgery of patients.World journal of gastroenterology · 2014Review
- Gastric electrical stimulation for the treatment of obesity: from entrainment to bezoars-a functional review.ISRN gastroenterology · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increasing incidence of obesity and overweight among children and adolescents will be reflected by the imminent increase in the number of obese patients who require more definitive methods of treatment. There is great interest in new, safe, simple, nonsurgical procedures for weight loss.
objectiveTo provide an overview of new endoscopic methods for the treatment of obesity.
methodsAn English-language literature search on endoscopic interventions, endoscopically placed devices and patient safety was performed in the MEDLINE and Cochrane Library databases.
resultsThe literature search yielded the following weight loss methods: space-occupying devices (widely used), gastric capacity reduction, modifying gastric motor function and malabsorptive procedures. A commercially available intragastric balloon was the most commonly used device for weight loss. In specific subgroups of patients, it improved quality of life, decreased comorbidities and served as a bridge to surgery. More evidence regarding the potential benefits and safety of other commercially available intragastric balloons is needed to clarify whether they are superior to the most commonly used one. Moreover, early experiences with transoral gastroplasty, the duodenal-jejunal bypass sleeve and an adjustable, totally implantable intragastric prosthesis, indicate that they may be viable options for obesity treatment. Other agents, such as botulinum toxin and a device known as the 'butterfly', are currently at the experimental stage.
conclusionNew endoscopic methods for weight loss may be valuable in the treatment of obesity; however, more clinical experience and technical improvements are necessary before implementing their widespread use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.